BNR (Burning Rock Biotech Limited American Depositary Shares) Stock Analysis

Burning Rock Biotech Limited American Depositary Shares (BNR) is a publicly traded Healthcare sector company. As of May 21, 2026, BNR trades at $17.25 with a market cap of $176.12M and a P/E ratio of 0.00. BNR moved +0.00% today. Year to date, BNR is -31.78%; over the trailing twelve months it is +473.88%. Its 52-week range spans $2.18 to $41.72. Rallies surfaces BNR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest BNR stock research?

Burning Rock Biotech Limited American Depositary Shares (BNR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BNR moved +0.00% today.

BNR Key Metrics

Key financial metrics for BNR
MetricValue
Price$17.25
Market Cap$176.12M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$41.72
52-Week Low$2.18
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BNR News

Recent BNR Insider Trades

  • Han Yusheng bought 314.87K (~$5.47M) on Mar 31, 2026.

BNR Analyst Consensus

BNR analyst coverage data. Average price target: $0.00.

Common questions about BNR

What can I research for BNR on Rallies?
Burning Rock Biotech Limited American Depositary Shares (BNR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BNR moved +0.00% today.
Does Rallies show live market data for BNR?
Rallies combines live market context with ticker research for BNR, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
BNR

BNR